Related Experiment Video

Updated: Jun 10, 2026

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

DCB-3503, a tylophorine analog, inhibits protein synthesis through a novel mechanism

Ying Wang1, Wenli Gao, Yuri V Svitkin

  • 1Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut, United States of America.

Plos One
|July 27, 2010
PubMed
Abstract

Insights

DCB-3503, a novel tylophorine analog, inhibits cancer growth by selectively degrading short-lived proteins, distinct from current therapies. This unique mechanism offers potential for new cancer treatments and overcoming drug resistance.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • DCB-3503, a tylophorine analog, inhibits growth of pancreatic (PANC-1) and liver (HepG2) cancer xenografts.
  • DCB-3503 induces cancer cell differentiation rather than apoptosis.
  • The precise mechanism of action for tylophorine analogs remains largely unknown.

Purpose of the Study:

  • To elucidate the molecular mechanism by which DCB-3503 inhibits cancer cell growth.
  • To investigate the effects of DCB-3503 on protein expression and synthesis.
  • To compare the mechanism of DCB-3503 with existing anticancer drugs.

Main Methods:

  • Assessed protein and mRNA levels of key oncogenic/survival proteins (cyclin D1, survivin, beta-catenin, p53, p21).
  • Utilized proteasome inhibitors to evaluate protein degradation pathways.
  • Measured incorporation of radiolabeled amino acid, thymidine, and uridine to assess protein synthesis.
  • Analyzed ribosome and mRNA profiles via sedimentation to determine the step of protein synthesis affected.
  • Compared DCB-3503's effects with cycloheximide and rapamycin, assessing mTOR pathway involvement.

Main Results:

  • DCB-3503 suppressed short-lived proteins (cyclin D1, survivin, beta-catenin, p53, p21) without altering mRNA levels, an effect reversed by proteasome inhibitors.
  • DCB-3503 inhibited protein synthesis, primarily affecting the elongation step, as evidenced by shifts in polysomal profiles.
  • The mechanism of protein synthesis inhibition by DCB-3503 is distinct from cycloheximide and does not involve the mTOR pathway.

Conclusions:

  • DCB-3503 exhibits a novel mechanism of action by inhibiting protein translation elongation and promoting degradation of short-lived proteins.
  • This distinct mechanism differentiates DCB-3503 from current protein synthesis inhibitors used in cancer therapy.
  • Novel translation inhibitors like DCB-3503 could serve as valuable adjuncts to existing chemotherapy, potentially overcoming drug resistance.

More Related Videos

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...